Agenus Inc. (AGEN)
USD 3.11
(8.74%)
USD 3.11
(8.74%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 139.61 Million USD | 240.69% |
| 2022 | -99.23 Million USD | -187.36% |
| 2021 | 113.58 Million USD | 299.99% |
| 2020 | -56.79 Million USD | -210.51% |
| 2019 | -18.29 Million USD | 79.17% |
| 2018 | -87.81 Million USD | -19.89% |
| 2017 | -73.24 Million USD | -1.17% |
| 2016 | -72.39 Million USD | -58.67% |
| 2015 | -45.62 Million USD | -196.82% |
| 2014 | -15.37 Million USD | -46.46% |
| 2013 | -10.49 Million USD | -322.18% |
| 2012 | 4.72 Million USD | 71.42% |
| 2011 | 2.75 Million USD | -14.86% |
| 2010 | 3.23 Million USD | -2.92% |
| 2009 | 3.33 Million USD | 25.76% |
| 2008 | 2.65 Million USD | -52.25% |
| 2007 | 5.55 Million USD | 702.2% |
| 2006 | 692.13 Thousand USD | 9.87% |
| 2005 | 629.97 Thousand USD | -10.29% |
| 2004 | 702.27 Thousand USD | -72.0% |
| 2003 | 2.5 Million USD | 20.91% |
| 2002 | 2.07 Million USD | -40.58% |
| 2001 | 3.49 Million USD | 98.89% |
| 2000 | 1.75 Million USD | 1655.24% |
| 1999 | 100 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 24.52 Million USD | -68.7% |
| 2024 Q2 | 20.03 Million USD | -4.61% |
| 2023 FY | 139.61 Million USD | 240.69% |
| 2023 Q3 | -27.43 Million USD | 19.89% |
| 2023 Q2 | -34.24 Million USD | 6.21% |
| 2023 Q4 | 78.34 Million USD | 385.58% |
| 2023 Q1 | -36.51 Million USD | -12.04% |
| 2022 Q3 | -23.54 Million USD | 9.64% |
| 2022 Q1 | -17.04 Million USD | 50.03% |
| 2022 FY | -99.23 Million USD | -187.36% |
| 2022 Q4 | -32.58 Million USD | -38.39% |
| 2022 Q2 | -26.05 Million USD | -52.89% |
| 2021 FY | 113.58 Million USD | 299.99% |
| 2021 Q2 | -35.44 Million USD | -36.0% |
| 2021 Q1 | -26.06 Million USD | -410.14% |
| 2021 Q4 | -34.1 Million USD | -116.3% |
| 2021 Q3 | 209.2 Million USD | 690.21% |
| 2020 Q4 | -5.1 Million USD | 71.95% |
| 2020 Q2 | -12.23 Million USD | 42.36% |
| 2020 Q1 | -21.23 Million USD | -810.2% |
| 2020 FY | -56.79 Million USD | -210.51% |
| 2020 Q3 | -18.21 Million USD | -48.81% |
| 2019 Q3 | -26.19 Million USD | 11.3% |
| 2019 Q4 | -2.33 Million USD | 91.09% |
| 2019 Q1 | 39.76 Million USD | 234.41% |
| 2019 Q2 | -29.52 Million USD | -174.26% |
| 2019 FY | -18.29 Million USD | 79.17% |
| 2018 Q3 | -17.05 Million USD | -27.45% |
| 2018 FY | -87.81 Million USD | -19.89% |
| 2018 Q1 | -27.8 Million USD | -18.23% |
| 2018 Q2 | -13.37 Million USD | 51.88% |
| 2018 Q4 | -29.58 Million USD | -73.48% |
| 2017 Q3 | -22.42 Million USD | -3.76% |
| 2017 FY | -73.24 Million USD | -1.17% |
| 2017 Q1 | -5.68 Million USD | 72.15% |
| 2017 Q2 | -21.61 Million USD | -280.3% |
| 2017 Q4 | -23.51 Million USD | -4.85% |
| 2016 Q3 | -17.14 Million USD | -8.7% |
| 2016 Q2 | -15.77 Million USD | 17.34% |
| 2016 FY | -72.39 Million USD | -58.67% |
| 2016 Q4 | -20.4 Million USD | -19.05% |
| 2016 Q1 | -19.07 Million USD | -85.05% |
| 2015 FY | -45.62 Million USD | -196.82% |
| 2015 Q2 | -18.39 Million USD | -249.27% |
| 2015 Q1 | -5.26 Million USD | 8.4% |
| 2015 Q4 | -10.31 Million USD | 11.53% |
| 2015 Q3 | -11.65 Million USD | 36.65% |
| 2014 FY | -15.37 Million USD | -46.46% |
| 2014 Q4 | -5.75 Million USD | -54.52% |
| 2014 Q2 | -2.14 Million USD | 42.72% |
| 2014 Q3 | -3.72 Million USD | -73.16% |
| 2014 Q1 | -3.75 Million USD | -31.42% |
| 2013 FY | -10.49 Million USD | -322.18% |
| 2013 Q4 | -2.85 Million USD | 11.8% |
| 2013 Q1 | -1.71 Million USD | -8.46% |
| 2013 Q3 | -3.23 Million USD | -20.47% |
| 2013 Q2 | -2.68 Million USD | -56.4% |
| 2012 Q1 | 13.35 Million USD | 1973.89% |
| 2012 Q4 | -1.58 Million USD | -342.94% |
| 2012 FY | 4.72 Million USD | 71.42% |
| 2012 Q2 | 499 Thousand USD | -96.26% |
| 2012 Q3 | 652 Thousand USD | 30.66% |
| 2011 Q1 | -5.02 Billion USD | -576904.31% |
| 2011 Q3 | -4.44 Billion USD | 5.54% |
| 2011 Q4 | 643.77 Thousand USD | 100.01% |
| 2011 FY | 2.75 Million USD | -14.86% |
| 2011 Q2 | -4.7 Billion USD | 6.39% |
| 2010 FY | 3.23 Million USD | -2.92% |
| 2010 Q4 | 870.61 Thousand USD | 55.63% |
| 2010 Q3 | 559.39 Thousand USD | -25.14% |
| 2010 Q2 | 747.27 Thousand USD | 100.01% |
| 2010 Q1 | -7.26 Billion USD | -1327849.83% |
| 2009 Q4 | 546.79 Thousand USD | 100.01% |
| 2009 Q3 | -6.36 Billion USD | 19.68% |
| 2009 Q2 | -7.92 Billion USD | 3.19% |
| 2009 Q1 | -8.18 Billion USD | -1569758.93% |
| 2009 FY | 3.33 Million USD | 25.76% |
| 2008 Q2 | -10.98 Billion USD | -8.15% |
| 2008 Q4 | 521.57 Thousand USD | 100.01% |
| 2008 Q1 | -10.15 Billion USD | -1136642.88% |
| 2008 FY | 2.65 Million USD | -52.25% |
| 2008 Q3 | -9.84 Billion USD | 10.36% |
| 2007 FY | 5.55 Million USD | 702.2% |
| 2007 Q4 | 893.28 Thousand USD | 100.01% |
| 2007 Q3 | -9.84 Billion USD | -9.41% |
| 2007 Q2 | -9 Billion USD | -13.35% |
| 2007 Q1 | -7.94 Billion USD | -2483987.39% |
| 2006 Q4 | 319.73 Thousand USD | 100.0% |
| 2006 Q1 | -15.05 Billion USD | -4321197.96% |
| 2006 Q2 | -13.82 Billion USD | 8.18% |
| 2006 FY | 692.13 Thousand USD | 9.87% |
| 2006 Q3 | -10.77 Billion USD | 22.04% |
| 2005 Q4 | 348.39 Thousand USD | 102.04% |
| 2005 Q2 | -21 Million USD | -17.56% |
| 2005 Q1 | -17.86 Million USD | -14005.85% |
| 2005 Q3 | -17.07 Million USD | 18.68% |
| 2005 FY | 629.97 Thousand USD | -10.29% |
| 2004 Q4 | 128.45 Thousand USD | -53.72% |
| 2004 Q1 | -146.91 Thousand USD | -127.68% |
| 2004 Q2 | -17.08 Million USD | -11526.79% |
| 2004 FY | 702.27 Thousand USD | -72.0% |
| 2004 Q3 | 277.55 Thousand USD | 101.62% |
| 2003 Q3 | 337.02 Thousand USD | -29.87% |
| 2003 Q1 | 1.15 Million USD | 152.38% |
| 2003 Q2 | 480.56 Thousand USD | -58.56% |
| 2003 FY | 2.5 Million USD | 20.91% |
| 2003 Q4 | 530.8 Thousand USD | 57.5% |
| 2002 FY | 2.07 Million USD | -40.58% |
| 2002 Q4 | 459.52 Thousand USD | -28.11% |
| 2002 Q3 | 639.23 Thousand USD | 56.61% |
| 2002 Q2 | 408.16 Thousand USD | -28.06% |
| 2002 Q1 | 567.39 Thousand USD | -53.58% |
| 2001 Q2 | 923.4 Thousand USD | -44.19% |
| 2001 Q1 | 1.65 Million USD | -5.74% |
| 2001 FY | 3.49 Million USD | 98.89% |
| 2001 Q4 | 1.22 Million USD | 77.81% |
| 2001 Q3 | 687.39 Thousand USD | -25.56% |
| 2000 Q3 | 1.00 USD | 0.0% |
| 2000 Q1 | 1.00 USD | 0.0% |
| 2000 Q2 | 1.00 USD | 0.0% |
| 2000 Q4 | 1.75 Million USD | 175523900.0% |
| 2000 FY | 1.75 Million USD | 1655.24% |
| 1999 FY | 100 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Absci Corporation | -41.84 Million USD | 433.616% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -47.393% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 90.802% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 275257.667% |
| Apollomics, Inc. | 127 Thousand USD | -109833.071% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 132217.341% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 607121.739% |
| Bicycle Therapeutics plc | -129.52 Million USD | 207.794% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -17308.354% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -116245.833% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -596.265% |
| Chimerix, Inc. | 324 Thousand USD | -42991.049% |
| CRISPR Therapeutics AG | 240.95 Million USD | 42.058% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -180.323% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -237.348% |
| Fortress Biotech, Inc. | 57.85 Million USD | -141.327% |
| Fortress Biotech, Inc. | 57.85 Million USD | -141.327% |
| Gritstone bio, Inc. | -6.26 Million USD | 2330.272% |
| Allakos Inc. | -6.14 Million USD | 2373.49% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 14688.819% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -843.727% |
| Cytokinetics, Incorporated | -322.59 Million USD | 143.279% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 79880.0% |
| Innoviva, Inc. | 261.06 Million USD | 46.521% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1223934.151% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 4031.709% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1389165.765% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 15947.333% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 35091.228% |
| ImmuCell Corporation | 4.39 Million USD | -3075.75% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 231.56% |
| Incyte Corporation | 3.44 Billion USD | 95.942% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 5326.035% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -71604.809% |
| Mustang Bio, Inc. | -2.22 Million USD | 6374.831% |
| MiMedx Group, Inc. | 266.84 Million USD | 47.679% |
| MEI Pharma, Inc. | 49.32 Million USD | -183.04% |
| MacroGenics, Inc. | 50.52 Million USD | -176.318% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1780.083% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 2064.843% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -380.52% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 0.419% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 450732.625% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 144032.99% |
| NextCure, Inc. | -3.68 Million USD | 3889.767% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -5324.048% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -633.157% |
| Onconetix, Inc. | -1.12 Million USD | 12486.385% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 581.963% |
| Opthea Limited | 21.72 Thousand USD | -642694.659% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 11687.461% |
| Psyence Biomedical Ltd. | -240.00 USD | 58173016.667% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 243645.686% |
| Precigen, Inc. | 106 Thousand USD | -131612.264% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -13736.967% |
| Prime Medicine, Inc. | -147.9 Million USD | 194.395% |
| PureTech Health plc | -1.6 Million USD | 8809.607% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 2066.963% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.765% |
| Replimune Group, Inc. | -2.65 Million USD | 5358.569% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 557467.56% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -27.186% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 27118.109% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 134.933% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -249.038% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 408.031% |
| Solid Biosciences Inc. | -76.56 Million USD | 282.353% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1163558.333% |
| SciSparc Ltd. | 2.19 Million USD | -6257.696% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 623.02% |
| TG Therapeutics, Inc. | 219.1 Million USD | 36.28% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -4512.322% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 8174.899% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -4.355% |
| UroGen Pharma Ltd. | 73.35 Million USD | -90.336% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -3089.013% |
| XOMA Corporation | 3.86 Million USD | -3516.032% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 10151.476% |
| AbCellera Biologics Inc. | 38.02 Million USD | -267.166% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2792400.0% |
| Cassava Sciences, Inc. | -89.42 Million USD | 256.129% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 547.948% |
| Precision BioSciences, Inc. | 40.47 Million USD | -244.967% |
| Dyadic International, Inc. | 922.95 Thousand USD | -15026.924% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 95076.19% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -562.908% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -32828.066% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1707.172% |
| IGM Biosciences, Inc. | -211.66 Million USD | 165.962% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 7094.739% |
| Acelyrin, Inc. | -115 Thousand USD | 121504.348% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -5633.676% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -16.586% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1145.191% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 9.804% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 242.15% |
| Senti Biosciences, Inc. | -2.68 Million USD | 5303.69% |
| Mesoblast Limited | -9.81 Million USD | 1522.466% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 226.361% |
| ChromaDex Corporation | 50.78 Million USD | -174.941% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -15.888% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -1886.836% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -3.213% |
| Novavax, Inc. | 639.93 Million USD | 78.183% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 242.228% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 421.227% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -107296.154% |
| Celcuity Inc. | -142.77 Thousand USD | 97888.782% |
| ContextLogic Inc. | 59 Million USD | -136.636% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -27009.709% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -742.221% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 95.892% |
| Amarin Corporation plc | 165.54 Million USD | 15.661% |
| AnaptysBio, Inc. | 14.78 Million USD | -844.557% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 24723.457% |
| Aptorum Group Limited | -1.11 Million USD | 12625.029% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -470.999% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 42.005% |
| Ardelyx, Inc. | 106.66 Million USD | -30.896% |
| Celularity Inc. | 6.75 Million USD | -1966.839% |
| Omeros Corporation | -69.77 Million USD | 300.082% |
| Humacyte, Inc. | -76.55 Million USD | 282.384% |
| Immunocore Holdings plc | 248.39 Million USD | 43.792% |
| IO Biotech, Inc. | -756 Thousand USD | 18567.593% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 9890.673% |
| Summit Therapeutics Inc. | -2.05 Million USD | 6910.488% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 3009.858% |
| Pulmatrix, Inc. | -8.22 Million USD | 1798.479% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 135.009% |
| Evogene Ltd. | 1.39 Million USD | -9879.628% |
| CorMedix Inc. | -205.56 Thousand USD | 68018.681% |
| BioLineRx Ltd. | 1.1 Million USD | -12500.632% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -28048.185% |
| Sagimet Biosciences Inc. | 2 Million USD | -6880.75% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 83.995% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1327.264% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 302.352% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 70.663% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1223934.151% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 481531.034% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 73970.37% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -3346.433% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 26693.333% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 316056.821% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1436.674% |
| Daré Bioscience, Inc. | 2.76 Million USD | -4941.123% |
| bluebird bio, Inc. | -4.03 Million USD | 3564.392% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 92.669% |
| DBV Technologies S.A. | 15.72 Million USD | -787.684% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 176.962% |
| Galecto, Inc. | -830 Thousand USD | 16921.084% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 24550.963% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 454.866% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -22825.287% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 97527.792% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -155.616% |
| ADMA Biologics, Inc. | 88.21 Million USD | -58.261% |
| Clene Inc. | 533 Thousand USD | -26094.184% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -6922.887% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 29520.814% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1342551.923% |
| Soligenix, Inc. | 97.31 Thousand USD | -143372.989% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1391.655% |
| Kura Oncology, Inc. | -849 Thousand USD | 16544.641% |
| Surrozen, Inc. | -27.23 Million USD | 612.725% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 308.058% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -40.97% |
| Autolus Therapeutics plc | -4.86 Million USD | 2968.605% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 83204.167% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 279.921% |
| GRI Bio, Inc. | 10.84 Million USD | -1187.842% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -5396.684% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 398.074% |
| INmune Bio, Inc. | 155 Thousand USD | -89974.194% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -125.407% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 9368.793% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 21630.44% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1844419.683% |
| Jaguar Health, Inc. | 7.72 Million USD | -1707.548% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 477024.916% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -34630.1% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1673.79% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 44705.431% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -47.802% |
| Verastem, Inc. | -62 Thousand USD | 225285.484% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 53592.337% |
| Histogen Inc. | 3.76 Million USD | -3604.298% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -24131.185% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 79.49% |
| Surrozen, Inc. | -27.23 Million USD | 612.725% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2690.74% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 7051362.626% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -2201.439% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 208073.961% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -95657.888% |
| Kronos Bio, Inc. | 1.37 Million USD | -10076.02% |
| Turnstone Biologics Corp. | 16.5 Million USD | -745.844% |
| Synaptogenix, Inc. | -6347.00 USD | 2199800.646% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 273854.902% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -379.299% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 13.479% |
| Exelixis, Inc. | 1.75 Billion USD | 92.057% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 224.477% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 58.704% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 12700.632% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 117927.514% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1807.83% |
| Insmed Incorporated | 239.63 Million USD | 41.738% |
| MediWound Ltd. | 3.57 Million USD | -3802.04% |
| OmniAb, Inc. | 14.66 Million USD | -851.899% |
| Alector, Inc. | -95.05 Million USD | 246.881% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -11.14% |
| Zai Lab Limited | 170.9 Million USD | 18.307% |
| AlloVir, Inc. | -398 Thousand USD | 35179.146% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -70.518% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 13628.585% |
| Aura Biosciences, Inc. | -1.29 Million USD | 10881.081% |
| Immunic, Inc. | -111 Thousand USD | 125879.279% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -780.629% |
| Veracyte, Inc. | 248.14 Million USD | 43.737% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.998% |
| FibroGen, Inc. | 128.9 Million USD | -8.309% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 55.49% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 24754532.624% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1296.678% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -35790.746% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 60.71% |
| Fortrea Holdings Inc. | 424 Million USD | 67.072% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 262.028% |
| XBiotech Inc. | -1.74 Million USD | 8105.447% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 12700.632% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 21126.355% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 400.435% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 284.837% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -90.203% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -730.893% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 64.113% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 381.215% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 57.272% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1332.93% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 244.007% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2585362.963% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 209020.047% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 79951.638% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 37430.214% |
| Ainos, Inc. | -253.73 Thousand USD | 55124.376% |
| Pluri Inc. | 322 Thousand USD | -43258.696% |
| Prothena Corporation plc | -129.2 Million USD | 208.06% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -176.882% |
| Rallybio Corporation | -150 Thousand USD | 93176.667% |
| Kodiak Sciences Inc. | -25.94 Million USD | 638.078% |
| Cue Biopharma, Inc. | -32.6 Million USD | 528.175% |
| MeiraGTx Holdings plc | 287 Thousand USD | -48546.341% |
| Annexon, Inc. | -3.26 Million USD | 4373.493% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 434.511% |
| Moderna, Inc. | 2.15 Billion USD | 93.521% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1020.397% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -123.807% |
| Blueprint Medicines Corporation | 236.58 Million USD | 40.987% |
| Immix Biopharma, Inc. | -5468.00 USD | 2553410.168% |
| CalciMedica, Inc. | -58 Thousand USD | 240815.517% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2343.893% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 5009.107% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -34.118% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 552.341% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 12032.906% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -4930.111% |
| Nutriband Inc. | 862.1 Thousand USD | -16094.663% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 41042.815% |
| Vor Biopharma Inc. | -3.49 Million USD | 4098.139% |
| Roivant Sciences Ltd. | 109.23 Million USD | -27.812% |
| Alkermes plc | 1.37 Billion USD | 89.844% |
| ProKidney Corp. | -3.16 Million USD | 4505.648% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 417.943% |
| Arcellx, Inc. | 108.27 Million USD | -28.94% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1936.095% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 277.467% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 423175.758% |
| Atai Life Sciences N.V. | -5000.00 USD | 2792400.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 114670.939% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 145532.292% |
| MediciNova, Inc. | 979.7 Thousand USD | -14150.718% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 265.58% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 147754.804% |
| GeoVax Labs, Inc. | -20.72 Million USD | 773.793% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 42.906% |
| Biomea Fusion, Inc. | -4.2 Million USD | 3423.375% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 45137.097% |
| Geron Corporation | -123.5 Million USD | 213.046% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2792400.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 282.807% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 5773.1% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 34.678% |
| Royalty Pharma plc | 1.79 Billion USD | 92.217% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 14936.876% |
| Imunon, Inc. | -720 Thousand USD | 19490.838% |
| BioAtla, Inc. | -103.73 Million USD | 234.593% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 157.498% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 44992.283% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 225.312% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 14809.105% |
| 89bio, Inc. | -273 Thousand USD | 51241.026% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 299.208% |
| aTyr Pharma, Inc. | -2.38 Million USD | 5946.524% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1020.506% |
| Viridian Therapeutics, Inc. | -1 Million USD | 13950.694% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1073961438.462% |
| Akari Therapeutics, Plc | -4000.00 USD | 3490475.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 78.079% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -12376.765% |
| Liquidia Corporation | 14.6 Million USD | -856.267% |
| Entera Bio Ltd. | -56 Thousand USD | 249412.5% |
| GH Research PLC | -315 Thousand USD | 44422.222% |
| Vericel Corporation | 135.57 Million USD | -2.979% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 351.291% |
| Xencor, Inc. | -85.26 Million USD | 263.752% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 63280.784% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 21630.44% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 14044.265% |
| Vaxcyte, Inc. | -75 Million USD | 286.153% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 183.346% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 21.496% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -71604.809% |
| Portage Biotech Inc. | -54 Thousand USD | 258646.296% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 147754.804% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 37133.156% |
| OncoCyte Corporation | 413 Thousand USD | -33705.085% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 3106106.674% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 62889739.64% |
| Purple Biotech Ltd. | -196 Thousand USD | 71332.143% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 36744.357% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 734.989% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -104.936% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1456.813% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 110033.071% |
| United Therapeutics Corporation | 2.07 Billion USD | 93.255% |
| HilleVax, Inc. | -2.15 Million USD | 6575.649% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -210595.098% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 3641.687% |
| Pharming Group N.V. | 220.1 Million USD | 36.569% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 930618.528% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 21000.449% |
| Pyxis Oncology, Inc. | -2 Million USD | 7080.75% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1860105.649% |
| Savara Inc. | -44.26 Million USD | 415.429% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 170362.195% |
| Curis, Inc. | 9.81 Million USD | -1323.046% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 111981.751% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 61334.649% |
| BeiGene, Ltd. | 2.07 Billion USD | 93.284% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -146.287% |
| Erasca, Inc. | -3.73 Million USD | 3841.024% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 494872.84% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 494872.84% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 15358.47% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1643.88% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 26147.575% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 225.634% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 3991.165% |
| Adicet Bio, Inc. | -6.09 Million USD | 2389.521% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 61.436% |
| Aditxt, Inc. | -111.66 Thousand USD | 125135.823% |
| Adagene Inc. | 18.11 Million USD | -670.864% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -28509.631% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 11.544% |
| Compugen Ltd. | 31.45 Million USD | -343.856% |
| Generation Bio Co. | -73.91 Million USD | 288.896% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 32048.513% |
| Invivyd, Inc. | -2.02 Million USD | 6984.369% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 146.408% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 135074.574% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -44.877% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -42.047% |
| Instil Bio, Inc. | -4.75 Million USD | 3035.555% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -479.095% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -12205.435% |
| GeoVax Labs, Inc. | -20.72 Million USD | 773.793% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 71949.462% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 16800.359% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -67.374% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -190860.444% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -162.622% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 180.615% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 39650.992% |
| Cingulate Inc. | -582.91 Thousand USD | 24051.053% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 450470.968% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 808.742% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 14231.073% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 247899.155% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 360.155% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 47913.356% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 26592.41% |
| ImmunityBio, Inc. | -17.89 Million USD | 880.408% |
| Korro Bio, Inc. | -3.63 Million USD | 3946.143% |
| Kineta, Inc. | 5.43 Million USD | -2469.759% |
| BioVie Inc. | -229.37 Thousand USD | 60967.044% |
| Codexis, Inc. | 57.33 Million USD | -143.512% |
| Celularity Inc. | 6.75 Million USD | -1966.839% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 117423.529% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -3379.068% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -275873.513% |
| Cibus, Inc. | 1.42 Million USD | -9718.214% |
| IN8bio, Inc. | -2.5 Million USD | 5682.367% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 6930.479% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -21714.844% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 82.066% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 19.277% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | -39 Thousand USD | 358087.179% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 7448.158% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 531.323% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -76.273% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 760.056% |
| Moolec Science SA | -143.3 Thousand USD | 97525.072% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 429.919% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -4147.49% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 299.194% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 7487.037% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 3865410.078% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -60237.265% |
| Humacyte, Inc. | -76.55 Million USD | 282.384% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 11207.001% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 16564.033% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 113608.13% |
| Notable Labs, Ltd. | 113 Thousand USD | -123453.097% |
| Immunovant, Inc. | -231 Thousand USD | 60539.394% |
| Quantum-Si incorporated | 488 Thousand USD | -28509.631% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 465483.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -7398.12% |
| Acasti Pharma Inc. | -11 Thousand USD | 1269327.273% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 68332.356% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 7230.49% |
| PepGen Inc. | -1.18 Million USD | 11891.807% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 709.752% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 169160.218% |
| Immuneering Corporation | -764.13 Thousand USD | 18370.914% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | -399 Thousand USD | 35091.228% |
| XOMA Corporation | 3.86 Million USD | -3516.032% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 796.821% |
| Bionomics Limited | -434.44 Thousand USD | 32236.108% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 13099.534% |
| uniQure N.V. | 2.21 Million USD | -6203.16% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 251.642% |
| Forte Biosciences, Inc. | -9000.00 USD | 1551377.778% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 16820.359% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 32048.513% |
| Altimmune, Inc. | -65.37 Million USD | 313.567% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 5900.374% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 13099.534% |
| Peak Bio, Inc. | 367.76 Thousand USD | -37862.689% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -469.485% |
| Benitec Biopharma Inc. | 108 Thousand USD | -129173.148% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 179093.59% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 11705.569% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 7762.733% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 11705.569% |
| argenx SE | 1.1 Billion USD | 87.405% |
| Immunome, Inc. | -8.9 Million USD | 1667.475% |
| Verona Pharma plc | -679.62 Thousand USD | 20642.977% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 79880.0% |
| Shattuck Labs, Inc. | -2.38 Million USD | 5953.878% |
| CervoMed Inc. | -1.29 Million USD | 10892.524% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 3022.65% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -5550.142% |
| Moolec Science SA | -143.3 Thousand USD | 97525.072% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 34316.847% |
| Design Therapeutics, Inc. | -537 Thousand USD | 26099.069% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 32796.721% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -6405.825% |
| Achilles Therapeutics plc | -4.73 Million USD | 3050.901% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 406.523% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -324586.047% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 17084.793% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1061165.511% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 423175.758% |
| Beam Therapeutics Inc. | -59.67 Million USD | 333.971% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -0.201% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -548.016% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 47108.418% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 3566.941% |
| NeurAxis, Inc. | 2.15 Million USD | -6373.536% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1559.492% |
| Lumos Pharma, Inc. | 2 Million USD | -6856.403% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -341.0% |
| Palisade Bio, Inc. | 246 Thousand USD | -56654.065% |
| Nutriband Inc. | 862.1 Thousand USD | -16094.663% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -891.584% |
| Neurogene Inc. | -3.26 Million USD | 4380.043% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 253945.455% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3881.555% |
| Athira Pharma, Inc. | -969 Thousand USD | 14508.153% |
| HCW Biologics Inc. | -574.82 Thousand USD | 24388.304% |
| XOMA Corporation | 3.86 Million USD | -3516.032% |
| Nektar Therapeutics | 53.47 Million USD | -161.07% |
| Arvinas, Inc. | 71.8 Million USD | -94.45% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 267.282% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 322.405% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 43458.696% |
| Rezolute, Inc. | -36 Thousand USD | 387919.444% |
| Clene Inc. | 533 Thousand USD | -26094.184% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 10873542.368% |
| BeyondSpring Inc. | 1.75 Million USD | -7873.444% |
| Synlogic, Inc. | -1.92 Million USD | 7356.497% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 377437.838% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 2304.912% |
| Peak Bio, Inc. | 367.76 Thousand USD | -37862.689% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 836.25% |
| Krystal Biotech, Inc. | 47.6 Million USD | -193.278% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 1.046% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2678.408% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 5492.167% |
| MannKind Corporation | 136.19 Million USD | -2.514% |
| Ikena Oncology, Inc. | -50.49 Million USD | 376.509% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -28.306% |
| Gossamer Bio, Inc. | -4.38 Million USD | 3283.922% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 55502.778% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2792400.0% |
| Legend Biotech Corporation | 140.92 Million USD | 0.932% |
| Mural Oncology plc | -2.56 Million USD | 5538.839% |
| Disc Medicine, Inc. | -100 Thousand USD | 139715.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -572.714% |
| REGENXBIO Inc. | 53.02 Million USD | -163.28% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2706.239% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 72674.399% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 8160.912% |
| Vaxart, Inc. | -60.76 Million USD | 329.77% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 53229.995% |
| Cellectis S.A. | 18 Thousand USD | -775538.889% |
| Longeveron Inc. | 221 Thousand USD | -63074.208% |
| Repare Therapeutics Inc. | -80.07 Million USD | 274.366% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 87.226% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 10889.413% |
| Revolution Medicines, Inc. | -399.66 Million USD | 134.933% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 399000.0% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -284828.571% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.378% |
| Denali Therapeutics Inc. | -93.34 Million USD | 249.569% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 557467.56% |
| Veru Inc. | 7.56 Million USD | -1745.312% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 92560.265% |
| Cingulate Inc. | -582.91 Thousand USD | 24051.053% |
| Passage Bio, Inc. | -3.72 Million USD | 3852.083% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1159307.904% |
| Exicure, Inc. | -1.42 Million USD | 9911.314% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 36553.003% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -5065.187% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 27332.652% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 93421.168% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 335.812% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -35607.161% |
| OmniAb, Inc. | 14.66 Million USD | -851.899% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -598.319% |
| Lipocine Inc. | -2.85 Million USD | 4997.366% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 7675.421% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2547.239% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 9368.793% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -85.372% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 214892.308% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -65.625% |
| Ocugen, Inc. | -33.53 Million USD | 516.301% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 4515.402% |
| Q32 Bio Inc. | 578 Thousand USD | -24054.844% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 52784.906% |
| Alumis Inc. Common Stock | -1.28 Million USD | 10973.442% |
| Equillium, Inc. | 35.95 Million USD | -288.272% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 8278.969% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -27785.132% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 3377337.542% |
| Dominari Holdings Inc. | 2.03 Million USD | -6747.229% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 76196.495% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1126.958% |
| Bio-Techne Corporation | 773.07 Million USD | 81.94% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -706.138% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 69.701% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 12043.114% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 682.214% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1093.597% |
| Nkarta, Inc. | -5.86 Million USD | 2478.855% |
| BioCardia, Inc. | -7.24 Million USD | 2025.99% |
| Iterum Therapeutics plc | -1.75 Million USD | 8078.0% |